New NSAID Inj Approved for Pain Management Hospira announced the launch of Bivalirudin for Injection, the first generic version of The Medicines Company's Angiomax. Hospira announced the launch of ...

Medicines Co. said the U.S. Patent and Trademark Office granted a one-year extension for the patent on its anticoagulant drug Angiomax, which accounts for almost all the company’s revenue.

PARSIPPANY, N.J., The Medicines Company today announced an agreement with Sandoz Inc. for the distribution of an authorized generic of ANGIOMAX® (bivalirudin) for injection in the United States.

CHICAGO (Reuters) - As the commonly used blood thinner heparin is recalled around the world and some doctors worry about shortages, researchers say the anti-clotting drug Angiomax works just as well.

Although a final judgment has not been released by the Court, on Mar 31, 2014, Judge Andrews in the U.S. District Court of Delaware issued his trial opinion regarding the generic Angiomax related ...

The Medicines Co. has been locked in a legal feud with the U.S. Patent and Trademark Office since 2001, when the company requested a patent extension on its best-selling drug Angiomax. On Monday ...

REPLACE-2 was a randomized, double-blind comparison of Angiomax with provisional use of platelet glycoprotein IIb/IIIa inhibitors versus heparin plus platelet glycoprotein IIb/IIIa inhibitors.

UCB-Bioproducts (UCB-Bio) today announced that it will provide commercial quantities of bivalirudin, the active pharmaceutical ingredient (API) for The Medicine Company's (NASDAQ: MDCO ...

Medicines Co. won a court ruling that may provide an additional four years of patent protection on its anticoagulant drug Angiomax, which accounts for almost all company revenue. The shares rose ...

But in Medicines Co.'s case, the full-court press isn't for reform, but for something much more specific: a patent extension on its anti-coagulant Angiomax. Medicines applied for a standard patent ...

The hospital care products company said that Angiomax’s expanded labeling now includes use of the agent in patients undergoing percutaneous coronary intervention with placement of a stent to ...

CHICAGO, March 29 (Reuters) - As the commonly used blood thinner heparin is recalled around the world and some doctors worry about shortages, researchers say the anti-clotting drug Angiomax works ...